TFF2 and gastric cancer: Organoids have also been useful in the study of the progression from gastritis to gastric cancer characterised by parietal cell loss and development of spasmolytic polypeptide/Trefoil Factor (TFF) 2-expressing metaplasia (SPEM) in its early stages [80,81].